Scores on the Negative Treatment Indicators content scale from the MMPI-2 were not significantly correlated with 5 measures of treatment outcome among 108 male patients on methadone maintenance. These results and those from other studies using this content scale as an independent variable with substance abusers suggest that the scale has yet to demonstrate consistent predictive validity with this population.
Get full access to this article
View all access options for this article.
References
1.
AaronsonL. A.DentO. B.KlineC. D. (1996) Cross-validation of MMPI and MMPI-2 predictor scales. Journal of Clinical Psychology, 52, 311–315.
2.
Ben-PorathY. S.SherwoodN. E. (1993) The MMPI-2 content component scales: Development, psychometric characteristics and clinical application. Minneapolis, MN: Univer. of Minnesota Press.
3.
ButcherJ. N.DahlstromW. G.GrahamJ. R.TellegenA.KaemmerB. (1989) Minnesota Multiphasic Personality Inventory-2: Manual for administration and scoring. Minneapolis, MN: National Computer Systems.
4.
ClarkeM. (1996) Negative Treatment Indicators content and content component scales: Clinical correlates and outcome prediction for men with chronic pain. Psychological Assessment, 8, 32–38.
5.
CraigR. J. (1999) Interpreting personality tests: A clinical manual for the MMPI-2, MCMI–III, CPI–R, and 16PF. New York: Wiley.
6.
GilmoreJ. D.LashS. J.FosterM. A.BlosserS. L. (2001) Adherence to substance abuse treatment: Clinical utility of two MMPI-2 scales. Journal of Personality Assessment, 77, 524–540.
SellsS. B.DemareeR. G.HornickC. W. (1979) Comparative effectiveness of drug abuse treatment modalities. Washington, DC: NIDA.
11.
Substance Abuse and Mental Health Services Administration. (2001) Opioid drugs in maintenance and detoxification treatment of opiate addiction; final rule. Federal Register. 21 CFR Part 291; 42 CFR Part 8. Wednesday, January 17.
